Form 4 for TYRA Tyra Biosciences, Inc.

Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-17 · accession 0000899243-21-036427 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2021-09-17	2021-09-17	TYRA	van den Boom Esther	CFO	C - Cnv Deriv	—	+21.3K	21.3K	New	—
D	2021-09-17	2021-09-17	TYRA	van den Boom Esther	CFO	C - Cnv Deriv	$0.00	-8,183	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-09-17	C	A	21,254	—	21,254	I See footnote	—	—	(F1) On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. (F2) Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.
2	Derivative	Series A Preferred Stock	2021-09-17	C	D	8,183	$0.00	0	D	— · — to —	21,254 Common Stock	(F1) On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.